These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. COX-1 sparing and COX-2 inhibitory drugs: the renal and hepatic safety and tolerability profiles of celecoxib. Whelton A Am J Ther; 2000 May; 7(3):151-2. PubMed ID: 11317163 [No Abstract] [Full Text] [Related]
8. [Acute liver failure and severe cholestasis due to sulfonamides]. Horák J; Mertl L; Hrabal P Cas Lek Cesk; 1985 Feb; 124(6):185-7. PubMed ID: 3871662 [No Abstract] [Full Text] [Related]
9. Toxic epidermal necrolysis as a complication of treatment with celecoxib. Perna AG; Woodruff CA; Markus RF; Hsu S Dermatol Online J; 2003 Dec; 9(5):25. PubMed ID: 14996398 [No Abstract] [Full Text] [Related]
10. Fatal allergic vasculitis associated with celecoxib. Schneider F; Meziani F; Chartier C; Alt M; Jaeger A Lancet; 2002 Mar; 359(9309):852-3. PubMed ID: 11897288 [TBL] [Abstract][Full Text] [Related]
12. [Cox-2 inhibitor in renal function]. García RE Rev Med Chil; 2000 Oct; 128(10):1177-8. PubMed ID: 11357864 [No Abstract] [Full Text] [Related]
13. Fulminant hepatic failure secondary to hydroxychloroquine. Makin AJ; Wendon J; Fitt S; Portmann BC; Williams R Gut; 1994 Apr; 35(4):569-70. PubMed ID: 8175002 [TBL] [Abstract][Full Text] [Related]
14. [Fulminant liver failure with a fatal outcome due to flutamide]. Fernández Peña CM; Morano Amado LE; Montes Santiago J; Fachal C Med Clin (Barc); 1997 Feb; 108(6):237-8. PubMed ID: 9102495 [No Abstract] [Full Text] [Related]